|
Market Closed -
Bombay S.E.
11:02:26 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.240 INR | +2.46% |
|
+3.65% | -23.34% |
| Market Cap | 376M 3.98M 3.43M 3.24M 2.95M 5.51M 5.55M 38.3M 14.87M 192M 14.95M 14.62M 632M | P/E 2024 |
-10.3x | P/E 2025 | -13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 443M 4.69M 4.04M 3.81M 3.47M 6.49M 6.54M 45.1M 17.5M 226M 17.6M 17.22M 744M | EV / Sales 2024 |
7.63x | EV / Sales 2025 | 8.85x |
| Free-Float |
22.51% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.46% | ||
| 1 week | +3.65% | ||
| Current month | -0.48% | ||
| 1 month | -5.02% | ||
| 3 months | -21.01% | ||
| 6 months | +4.00% | ||
| Current year | -23.34% |
| 1 week | 5.8 | 6.49 | |
| 1 month | 5.8 | 7.28 | |
| Current year | 5.71 | 8.87 | |
| 1 year | 5.71 | 10.75 | |
| 3 years | 5.71 | 19.7 | |
| 5 years | 5.71 | 19.7 | |
| 10 years | 4.51 | 56.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Murali Meraga
CEO | Chief Executive Officer | - | - |
Suneel Pachipala
DFI | Director of Finance/CFO | - | - |
Barkha Jain
CMP | Compliance Officer | - | 09/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dhananjaya Alli
CHM | Chairman | 76 | 01/01/2014 |
| Director/Board Member | 87 | 15/06/1993 | |
| Director/Board Member | 76 | 01/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.46% | +3.65% | -38.58% | -58.15% | 3.97M | ||
| -0.81% | +0.14% | +21.37% | +72.78% | 49.06B | ||
| +0.41% | +0.49% | +52.69% | +119.28% | 40.37B | ||
| -0.97% | -3.88% | +13.37% | +84.21% | 12.19B | ||
| -1.28% | -1.78% | -11.64% | +12.58% | 12.08B | ||
| +0.57% | +0.95% | +29.02% | +153.11% | 9.14B | ||
| 0.00% | -4.19% | +23.91% | +43.34% | 7.36B | ||
| -0.04% | -0.04% | +22.68% | +222.92% | 7.35B | ||
| +0.81% | +1.38% | +44.31% | -10.54% | 7.32B | ||
| -1.29% | -1.78% | -40.82% | +14.36% | 5.19B | ||
| Average | -0.01% | -0.20% | +11.63% | +65.39% | 15.01B | |
| Weighted average by Cap. | -0.31% | +0.35% | +26.11% | +86.09% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 103M 1.09M 940K 885K 806K 1.51M 1.52M 10.48M 4.07M 52.6M 4.09M 4M 173M | 101M 1.07M 920K 867K 790K 1.48M 1.49M 10.26M 3.98M 51.51M 4M 3.92M 169M |
| Net income | -45.12M -478K -412K -388K -354K -661K -666K -4.6M -1.78M -23.07M -1.79M -1.75M -75.78M | -46.49M -492K -425K -400K -364K -681K -686K -4.73M -1.84M -23.77M -1.85M -1.81M -78.07M |
| Net Debt | 78.7M 833K 719K 677K 617K 1.15M 1.16M 8.02M 3.11M 40.24M 3.13M 3.06M 132M | 66.71M 706K 609K 574K 523K 977K 985K 6.79M 2.64M 34.11M 2.65M 2.59M 112M |
Employees
30
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | ₹6.240 | +2.46% | 2,240 |
| 02/09/26 | ₹6.090 | +1.50% | 4,905 |
| 01/09/26 | ₹6.000 | -4.31% | 5,939 |
| 31/08/26 | ₹6.270 | -1.10% | 9,143 |
| 28/08/26 | ₹6.340 | +5.32% | 8,559 |
- Stock Market
- Stocks
- VISTAPH6 Stock
Select your edition
All financial news and data tailored to specific country editions
















